PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098164
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098164
Biobanking Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Biobanking Market is poised for sustained growth as healthcare systems, pharmaceutical companies, and research institutions continue to expand investments in biological sample preservation and advanced medical research. Biobanks have become an essential foundation for modern healthcare by securely storing biological specimens that support disease research, clinical trials, drug discovery, and precision medicine initiatives.
Growing interest in genomics, personalized treatment approaches, and regenerative medicine is increasing the need for reliable sample collection, storage, and management solutions. Continuous technological innovation in cryogenic storage, laboratory automation, and digital monitoring systems is further enhancing the efficiency and reliability of biobanking operations.
The global Biobanking Market is anticipated to grow from US$ 8.4 Billion in 2026 to US$ 15.5 Billion by 2033, registering a CAGR of 9% during the forecast period.
Market Insights
Biobanking has become an integral part of life science research by enabling the long term preservation of blood, tissues, cells, and other biological materials. These samples provide researchers with valuable resources for studying diseases, identifying biomarkers, and developing innovative therapeutic solutions.
Healthcare organizations are increasingly adopting automated storage technologies and digital sample tracking systems to improve operational accuracy while maintaining sample integrity. The growing number of collaborative research projects between academic institutions, biotechnology companies, and pharmaceutical organizations is also driving demand for standardized biobanking infrastructure.
The market continues to benefit from rising investments in biomedical innovation, increasing clinical research activities, and expanding applications of biological samples across multiple therapeutic areas.
Key Growth Drivers
One of the primary factors supporting market expansion is the growing adoption of precision medicine. Personalized treatment strategies require access to high quality biological samples that enable researchers to understand genetic variations and develop targeted therapies.
The increasing incidence of chronic diseases, cancer, and rare genetic disorders has significantly expanded biomedical research activities across the globe. As healthcare providers and pharmaceutical companies intensify research efforts, demand for advanced biobanking solutions continues to rise.
Technological advancements in cryogenic preservation, automated storage systems, laboratory information management software, and temperature monitoring technologies are improving operational efficiency while reducing the risk of sample degradation.
In addition, increasing government funding for life science research and national biobank initiatives is encouraging the development of advanced biological sample repositories that support long term healthcare innovation.
Business Opportunities
The Biobanking Market offers significant growth opportunities for companies developing advanced storage equipment, laboratory automation systems, sample management software, and cold chain logistics solutions.
Emerging economies are expanding healthcare infrastructure and increasing investments in biotechnology research, creating favorable conditions for the establishment of new biobanking facilities. Organizations capable of delivering integrated storage, monitoring, and sample management solutions are expected to gain a competitive advantage.
The expanding role of regenerative medicine, stem cell research, and genomic sequencing will continue creating new opportunities for biobank operators and technology providers. Strategic collaborations between healthcare organizations and research institutions are also expected to strengthen market development over the coming years.
Regional Analysis
North America continues to represent a major market due to its advanced healthcare infrastructure, significant research funding, and strong presence of biotechnology and pharmaceutical companies. Extensive clinical research activities and widespread adoption of advanced laboratory technologies continue to support regional market growth.
Europe maintains a strong position through continuous investments in biomedical research, well established healthcare systems, and collaborative scientific programs. Increasing emphasis on precision medicine and population health studies is further supporting demand for biobanking solutions.
Asia Pacific is expected to experience substantial growth as governments invest in healthcare modernization, biotechnology innovation, and scientific research capabilities. Expanding clinical trial activities and growing awareness of personalized healthcare are creating new opportunities throughout the region.
Latin America and the Middle East and Africa are gradually strengthening their research infrastructure, contributing to the adoption of modern biological sample storage technologies and supporting future market expansion.
Competitive Landscape
Leading companies operating in the Biobanking Market continue to focus on technological innovation, product development, strategic partnerships, and global expansion. Investments in automated storage systems, advanced cryogenic technologies, and digital laboratory management platforms are helping organizations improve efficiency while ensuring the highest standards of sample preservation.
Companies are also strengthening service capabilities by offering comprehensive storage solutions, monitoring technologies, logistics support, and laboratory management systems that meet evolving customer requirements across research and healthcare sectors.
Future Outlook
The outlook for the Biobanking Market remains highly positive as biological sample repositories become increasingly important for healthcare innovation and scientific advancement. Continuous improvements in automation, digital technologies, and sample preservation techniques are expected to enhance operational performance while supporting expanding research requirements.
Growing investments in precision medicine, regenerative therapies, genomics, and life science research will continue driving long term demand for advanced biobanking solutions. As global healthcare systems place greater emphasis on data driven medical research and personalized treatment strategies, the market is expected to witness steady and sustainable growth through 2033.
Key Players
- Thermo Fisher Scientific
- Qiagen N.V.
- Merck KGaA (MilliporeSigma)
- Sartorius AG
- Eppendorf AG
- Brooks Automation
- Chart Industries, Inc.
- Helmer Scientific
- BD (Becton, Dickinson and Company)
- Cryoport, Inc.
- Cytiva (part of Danaher)
- PerkinElmer, Inc.
- Greiner Bio One International GmbH
- PHC Corporation (formerly Panasonic Healthcare)
- BioStorage Technologies
Market Segmentation
By Sample Storage
- Blood
- Cells & Tissues
- Others
By Application
- Regenerative Medicines
- Life Science
- Others
By Settings
- Academic Medical Institutions
- Pharmaceutical & Biotechnological Companies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Biobanking Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Biobanking Market Outlook, 2020-2033
- 3.1. Global Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
- 3.1.1. Blood
- 3.1.2. Cells & Tissues
- 3.1.3. Others
- 3.2. Global Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Regenerative Medicines
- 3.2.2. Life Science
- 3.2.3. Others
- 3.3. Global Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
- 3.3.1. Academic Medical Institutions
- 3.3.2. Pharmaceutical & Biotechnological Companies
- 3.4. Global Biobanking Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Biobanking Market Outlook, 2020-2033
- 4.1. North America Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
- 4.1.1. Blood
- 4.1.2. Cells & Tissues
- 4.1.3. Others
- 4.2. North America Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Regenerative Medicines
- 4.2.2. Life Science
- 4.2.3. Others
- 4.3. North America Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
- 4.3.1. Academic Medical Institutions
- 4.3.2. Pharmaceutical & Biotechnological Companies
- 4.4. North America Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Biobanking Market Outlook, by Sample Storage, 2020-2033
- 4.4.2. U.S. Biobanking Market Outlook, by Application, 2020-2033
- 4.4.3. U.S. Biobanking Market Outlook, by Settings, 2020-2033
- 4.4.4. Canada Biobanking Market Outlook, by Sample Storage, 2020-2033
- 4.4.5. Canada Biobanking Market Outlook, by Application, 2020-2033
- 4.4.6. Canada Biobanking Market Outlook, by Settings, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Biobanking Market Outlook, 2020-2033
- 5.1. Europe Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
- 5.1.1. Blood
- 5.1.2. Cells & Tissues
- 5.1.3. Others
- 5.2. Europe Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Regenerative Medicines
- 5.2.2. Life Science
- 5.2.3. Others
- 5.3. Europe Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
- 5.3.1. Academic Medical Institutions
- 5.3.2. Pharmaceutical & Biotechnological Companies
- 5.4. Europe Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.2. Germany Biobanking Market Outlook, by Application, 2020-2033
- 5.4.3. Germany Biobanking Market Outlook, by Settings, 2020-2033
- 5.4.4. Italy Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.5. Italy Biobanking Market Outlook, by Application, 2020-2033
- 5.4.6. Italy Biobanking Market Outlook, by Settings, 2020-2033
- 5.4.7. France Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.8. France Biobanking Market Outlook, by Application, 2020-2033
- 5.4.9. France Biobanking Market Outlook, by Settings, 2020-2033
- 5.4.10. U.K. Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.11. U.K. Biobanking Market Outlook, by Application, 2020-2033
- 5.4.12. U.K. Biobanking Market Outlook, by Settings, 2020-2033
- 5.4.13. Spain Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.14. Spain Biobanking Market Outlook, by Application, 2020-2033
- 5.4.15. Spain Biobanking Market Outlook, by Settings, 2020-2033
- 5.4.16. Russia Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.17. Russia Biobanking Market Outlook, by Application, 2020-2033
- 5.4.18. Russia Biobanking Market Outlook, by Settings, 2020-2033
- 5.4.19. Rest of Europe Biobanking Market Outlook, by Sample Storage, 2020-2033
- 5.4.20. Rest of Europe Biobanking Market Outlook, by Application, 2020-2033
- 5.4.21. Rest of Europe Biobanking Market Outlook, by Settings, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biobanking Market Outlook, 2020-2033
- 6.1. Asia Pacific Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
- 6.1.1. Blood
- 6.1.2. Cells & Tissues
- 6.1.3. Others
- 6.2. Asia Pacific Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Regenerative Medicines
- 6.2.2. Life Science
- 6.2.3. Others
- 6.3. Asia Pacific Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
- 6.3.1. Academic Medical Institutions
- 6.3.2. Pharmaceutical & Biotechnological Companies
- 6.4. Asia Pacific Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Biobanking Market Outlook, by Sample Storage, 2020-2033
- 6.4.2. China Biobanking Market Outlook, by Application, 2020-2033
- 6.4.3. China Biobanking Market Outlook, by Settings, 2020-2033
- 6.4.4. Japan Biobanking Market Outlook, by Sample Storage, 2020-2033
- 6.4.5. Japan Biobanking Market Outlook, by Application, 2020-2033
- 6.4.6. Japan Biobanking Market Outlook, by Settings, 2020-2033
- 6.4.7. South Korea Biobanking Market Outlook, by Sample Storage, 2020-2033
- 6.4.8. South Korea Biobanking Market Outlook, by Application, 2020-2033
- 6.4.9. South Korea Biobanking Market Outlook, by Settings, 2020-2033
- 6.4.10. India Biobanking Market Outlook, by Sample Storage, 2020-2033
- 6.4.11. India Biobanking Market Outlook, by Application, 2020-2033
- 6.4.12. India Biobanking Market Outlook, by Settings, 2020-2033
- 6.4.13. Southeast Asia Biobanking Market Outlook, by Sample Storage, 2020-2033
- 6.4.14. Southeast Asia Biobanking Market Outlook, by Application, 2020-2033
- 6.4.15. Southeast Asia Biobanking Market Outlook, by Settings, 2020-2033
- 6.4.16. Rest of SAO Biobanking Market Outlook, by Sample Storage, 2020-2033
- 6.4.17. Rest of SAO Biobanking Market Outlook, by Application, 2020-2033
- 6.4.18. Rest of SAO Biobanking Market Outlook, by Settings, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biobanking Market Outlook, 2020-2033
- 7.1. Latin America Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
- 7.1.1. Blood
- 7.1.2. Cells & Tissues
- 7.1.3. Others
- 7.2. Latin America Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Regenerative Medicines
- 7.2.2. Life Science
- 7.2.3. Others
- 7.3. Latin America Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
- 7.3.1. Academic Medical Institutions
- 7.3.2. Pharmaceutical & Biotechnological Companies
- 7.4. Latin America Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Biobanking Market Outlook, by Sample Storage, 2020-2033
- 7.4.2. Brazil Biobanking Market Outlook, by Application, 2020-2033
- 7.4.3. Brazil Biobanking Market Outlook, by Settings, 2020-2033
- 7.4.4. Mexico Biobanking Market Outlook, by Sample Storage, 2020-2033
- 7.4.5. Mexico Biobanking Market Outlook, by Application, 2020-2033
- 7.4.6. Mexico Biobanking Market Outlook, by Settings, 2020-2033
- 7.4.7. Argentina Biobanking Market Outlook, by Sample Storage, 2020-2033
- 7.4.8. Argentina Biobanking Market Outlook, by Application, 2020-2033
- 7.4.9. Argentina Biobanking Market Outlook, by Settings, 2020-2033
- 7.4.10. Rest of LATAM Biobanking Market Outlook, by Sample Storage, 2020-2033
- 7.4.11. Rest of LATAM Biobanking Market Outlook, by Application, 2020-2033
- 7.4.12. Rest of LATAM Biobanking Market Outlook, by Settings, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biobanking Market Outlook, 2020-2033
- 8.1. Middle East & Africa Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
- 8.1.1. Blood
- 8.1.2. Cells & Tissues
- 8.1.3. Others
- 8.2. Middle East & Africa Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Regenerative Medicines
- 8.2.2. Life Science
- 8.2.3. Others
- 8.3. Middle East & Africa Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
- 8.3.1. Academic Medical Institutions
- 8.3.2. Pharmaceutical & Biotechnological Companies
- 8.4. Middle East & Africa Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Biobanking Market Outlook, by Sample Storage, 2020-2033
- 8.4.2. GCC Biobanking Market Outlook, by Application, 2020-2033
- 8.4.3. GCC Biobanking Market Outlook, by Settings, 2020-2033
- 8.4.4. South Africa Biobanking Market Outlook, by Sample Storage, 2020-2033
- 8.4.5. South Africa Biobanking Market Outlook, by Application, 2020-2033
- 8.4.6. South Africa Biobanking Market Outlook, by Settings, 2020-2033
- 8.4.7. Egypt Biobanking Market Outlook, by Sample Storage, 2020-2033
- 8.4.8. Egypt Biobanking Market Outlook, by Application, 2020-2033
- 8.4.9. Egypt Biobanking Market Outlook, by Settings, 2020-2033
- 8.4.10. Nigeria Biobanking Market Outlook, by Sample Storage, 2020-2033
- 8.4.11. Nigeria Biobanking Market Outlook, by Application, 2020-2033
- 8.4.12. Nigeria Biobanking Market Outlook, by Settings, 2020-2033
- 8.4.13. Rest of Middle East Biobanking Market Outlook, by Sample Storage, 2020-2033
- 8.4.14. Rest of Middle East Biobanking Market Outlook, by Application, 2020-2033
- 8.4.15. Rest of Middle East Biobanking Market Outlook, by Settings, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Qiagen N.V.
- 9.4.3. Merck KGaA (MilliporeSigma)
- 9.4.4. Sartorius AG
- 9.4.5. Eppendorf AG
- 9.4.6. Brooks Automation
- 9.4.7. Chart Industries, Inc.
- 9.4.8. Helmer Scientific
- 9.4.9. BD (Becton, Dickinson and Company)
- 9.4.10. Cryoport, Inc.
- 9.4.1. Thermo Fisher Scientific
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
